Article
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study
Rating:
0.0
Views:
46
Likes:
1
Library:
1
Atara Biotherapeutics said a patient in an early-stage study of its CAR-T cell therapy has died. | Atara Biotherapeutics said a patient in an early-stage study of its CAR-T cell therapy has died. The biotech and the study sponsor are evaluating "the extent of the relationship" of the death to the treatment.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value